Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

May 31, 2024

Study Completion Date

December 31, 2024

Conditions
Chronic Kidney Disease
Interventions
DRUG

Pirfenidone

Pirfenidone vs. matching placebo

DRUG

matching placebo

matching placebo

Trial Locations (2)

92161

RECRUITING

VA San Diego Healthcare System, San Diego

94143

RECRUITING

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

San Diego Veterans Healthcare System

FED

collaborator

University of California, San Diego

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

Genentech, Inc.

INDUSTRY

lead

Veterans Medical Research Foundation

OTHER